Hannah Hardwicke is a skilled Molecular Technologist at Inivata since April 2022, with prior experience as an NGS Team Supervisor at Oncologica UK from October 2020 to March 2022, where oversight of a team and processing oncology and SARS-CoV-2 samples in a high-throughput clinical environment were key responsibilities. Prior to this role, Hannah worked as a Genetic Technologist at Oncologica Ltd for 14 months, focusing on RNA extractions and RT-PCR, contributing to the organization being the first UKAS approved COVID-19 test and sequencing provider in the UK. Earlier experience includes a position as an Assistant Technical Officer at St George's University Hospitals NHS Foundation Trust, gaining expertise in Pharmacy Quality Control within both Chemistry and Microbiology. Hannah holds a Bachelor of Science degree in Biomedical Sciences from Brunel University London and A Levels in Biology, Chemistry, and Physical Education from Ormiston Sudbury Academy.